Analysis of aggregates and particles in protein pharmaceuticals
I tiakina i:
| Kaituhi rangatōpū: | |
|---|---|
| Ētahi atu kaituhi: | , |
| Hōputu: | Tāhiko īPukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
Hoboken, N.J. :
John Wiley & Sons, Inc.,
2012.
|
| Ngā marau: | |
| Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Rārangi ihirangi:
- The critical need for robust assays for quantitation and characterization of aggregates of therapeutic proteins
- Separation based analytical methods for measuring protein aggregation
- Laser light scattering-based techniques used for the characterization of protein therapeutics
- Online detection methods and emerging techniques for soluble aggregates in protein pharmaceuticals
- Analytical methods to measure sub-visible particulates
- Detection of visible particles in parenteral products
- Characterization of aggregates and particles using emerging techniques
- Ultraviolet absorption spectroscopy
- Fluorescence spectroscopy to characterize protein aggregates and particles
- Infrared spectroscopy to characterize protein aggregates
- Raman microscopy for characterization of particles
- Microscopic methods for particle characterization in protein pharmaceuticals
- Comparison of methods for soluble aggregate detection and size characterization
- Protein purification and its relation to protein aggregation and particles
- Formulation development and its relation to protein aggregation and particles.